Canadian regulators said Thursday Medicago’s two-dose vaccine can be given to adults ages 18 to 64, but said there’s too little data on the shots in people 65 and older. The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 — although that was before the omicron variant emerged. Side effects were mild…